Literature DB >> 1703981

Developmentally programmed induction of differentiation inhibiting activity and the control of stem cell populations.

P D Rathjen1, J Nichols, S Toth, D R Edwards, J K Heath, A G Smith.   

Abstract

Differentiation inhibiting activity/leukemia inhibitory factor (DIA/LIF) is a glycoprotein that controls differentiation of pluripotential stem cells. Alternative transcription generates both diffusible and matrix-associated forms of DIA/LIF. Transcriptional analysis using a sensitive ribonuclease protection assay revealed that the two messages are expressed independently, consistent with the proposition that the two forms of DIA/LIF have distinct biological roles. DIA/LIF expression was found to be activated early during differentiation of embryonic stem (ES) cells, providing a mechanism for feedback regulation of stem cell renewal. Expression of DIA/LIF by mesenchymal cells was shown to be controlled in a paracrine manner by polypeptide regulatory factors. Specific expression of the two forms of DIA/LIF was also demonstrated in the egg cylinder-stage mouse embryo. The combination of cell type-specific and signal-specific regulation enables very precise control over DIA/LIF expression and may represent an important component of the regulatory networks that govern stem cell proliferation and differentiation during mammalian development.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1703981     DOI: 10.1101/gad.4.12b.2308

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   11.361


  24 in total

1.  Epigenetic Interactions and Gene Expression in Peri-Implantation Mouse Embryo Development.

Authors:  Jean J Latimer; Roger A Pedersen
Journal:  Mod Cell Biol       Date:  1993

2.  Regulation of Oct-4 gene expression during differentiation of EC cells.

Authors:  J Schoorlemmer; L Jonk; S Sanbing; A van Puijenbroek; A Feijen; W Kruijer
Journal:  Mol Biol Rep       Date:  1995       Impact factor: 2.316

3.  cDNA cloning and tissue-specific expression of the phosphatidylcholine transfer protein gene.

Authors:  T B Geijtenbeek; A J Smith; P Borst; K W Wirtz
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

4.  Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation.

Authors:  H Bhatt; L J Brunet; C L Stewart
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

5.  Intracellular and extracellular leukemia inhibitory factor proteins have different cellular activities that are mediated by distinct protein motifs.

Authors:  B P Haines; R B Voyle; P D Rathjen
Journal:  Mol Biol Cell       Date:  2000-04       Impact factor: 4.138

6.  Dicistronic targeting constructs: reporters and modifiers of mammalian gene expression.

Authors:  P Mountford; B Zevnik; A Düwel; J Nichols; M Li; C Dani; M Robertson; I Chambers; A Smith
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

7.  Removal of LIF (leukemia inhibitory factor) results in increased vitamin A (retinol) metabolism to 4-oxoretinol in embryonic stem cells.

Authors:  M A Lane; A C Chen; S D Roman; F Derguini; L J Gudas
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 8.  Regulation of embryonic stem cell self-renewal and pluripotency by leukaemia inhibitory factor.

Authors:  Hiroyuki Hirai; Peter Karian; Nobuaki Kikyo
Journal:  Biochem J       Date:  2011-08-15       Impact factor: 3.857

9.  Stress Forces First Lineage Differentiation of Mouse Embryonic Stem Cells; Validation of a High-Throughput Screen for Toxicant Stress.

Authors:  Quanwen Li; Erica Louden; Jordan Zhou; Sascha Drewlo; Jing Dai; Elizabeth E Puscheck; Kang Chen; Daniel A Rappolee
Journal:  Stem Cells Dev       Date:  2019-01-07       Impact factor: 3.272

10.  LIF removal increases CRABPI and CRABPII transcripts in embryonic stem cells cultured in retinol or 4-oxoretinol.

Authors:  Michelle A Lane; Juliana Xu; Elana W Wilen; Renia Sylvester; Fadila Derguini; Lorraine J Gudas
Journal:  Mol Cell Endocrinol       Date:  2007-10-06       Impact factor: 4.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.